88 related articles for article (PubMed ID: 7308668)
21. Stable expression of a cDNA encoding rat brain protein kinase C-beta I confers a multidrug-resistant phenotype on rat fibroblasts.
Fan D; Fidler IJ; Ward NE; Seid C; Earnest LE; Housey GM; O'Brian CA
Anticancer Res; 1992; 12(3):661-7. PubMed ID: 1622123
[TBL] [Abstract][Full Text] [Related]
22. [Studies on the mechanism of multidrug resistance].
Inaba M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):807-14. PubMed ID: 3471182
[TBL] [Abstract][Full Text] [Related]
23. In vivo cisplatin resistance of rat ascites hepatoma AH66.
Minamino T; Nomura M; Tamai M; Moritani S; Ohshima T; Miyamoto K
Cancer Lett; 1996 Nov; 108(2):153-6. PubMed ID: 8973588
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of vincristine and actinomycin D by a new synthetic imidazole anti-tumor agent YM534 active against human cancer cells and multidrug-resistant cells.
Sato S; Watanabe Y; Okamura K; Hamanaka R; Mori T; Kohno K; Kuwano M
Anticancer Drug Des; 1989 Aug; 4(2):125-35. PubMed ID: 2803461
[TBL] [Abstract][Full Text] [Related]
25. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR
Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379
[TBL] [Abstract][Full Text] [Related]
26. Vincristine-resistant human leukemia cell line: new monoclonal antibodies to a 65kDa membrane protein.
Kakihara T; Yamada T; Fukuda T; Ohnishi Y; Kishi K; Shibata A
Leuk Lymphoma; 1992 May; 7(1-2):157-64. PubMed ID: 1472928
[TBL] [Abstract][Full Text] [Related]
27. Glutathione-S-transferase P-form dependent chlorambucil resistance in Yoshida rat ascites hepatoma cell lines.
Miyamoto K; Wakabayashi D; Minamino T; Nomura M
Cancer Lett; 1994 Apr; 78(1-3):77-83. PubMed ID: 7910111
[TBL] [Abstract][Full Text] [Related]
28. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression.
Slapak CA; Daniel JC; Levy SB
Cancer Res; 1990 Dec; 50(24):7895-901. PubMed ID: 1979251
[TBL] [Abstract][Full Text] [Related]
29. Isolation and preliminary characterization of an Adriamycin-resistant murine fibrosarcoma cell line.
Giavazzi R; Scholar E; Hart IR
Cancer Res; 1983 May; 43(5):2216-22. PubMed ID: 6831444
[TBL] [Abstract][Full Text] [Related]
30. Cross resistance between actinomycin-D, adriamycin and vincristine in a murine solid tumour in vivo.
Kaye SB; Boden JA
Biochem Pharmacol; 1980 Apr; 29(7):1081-4. PubMed ID: 7387723
[No Abstract] [Full Text] [Related]
31. Establishment and properties of vincristine-resistant human myelogenous leukemia K562.
Tsuruo T; Iida H; Ohkochi E; Tsukagoshi S; Sakurai Y
Gan; 1983 Oct; 74(5):751-8. PubMed ID: 6580255
[TBL] [Abstract][Full Text] [Related]
32. Acquired drug resistance in human lung carcinoma xenografts.
Volm M; Efferth T; Mattern J
Arzneimittelforschung; 1989 Aug; 39(8):828-31. PubMed ID: 2818670
[TBL] [Abstract][Full Text] [Related]
33. Cross-resistance of vincristine-resistant sublines of P388 leukemia to mitoxantrone with special emphasis on the relationship between in vitro and in vivo cross-resistance.
Inaba M; Nagashima K; Sakurai Y
Gan; 1984 Jul; 75(7):625-30. PubMed ID: 6468847
[TBL] [Abstract][Full Text] [Related]
34. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
35. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
Gutierrez PL; Wilder PJ; Biswal N
Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
[TBL] [Abstract][Full Text] [Related]
36. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of DNA biosynthesis by vincristine and pentoxifylline in murine P388 leukemia cells resistant to doxorubicin.
Chitnis MP; Viladkar AB; Juvekar AS
Neoplasma; 1990; 37(6):619-26. PubMed ID: 2274081
[TBL] [Abstract][Full Text] [Related]
38. Bovine serum albumin-doxorubicin conjugate overcomes multidrug resistance in a rat hepatoma.
Ohkawa K; Hatano T; Yamada K; Joh K; Takada K; Tsukada Y; Matsuda M
Cancer Res; 1993 Sep; 53(18):4238-42. PubMed ID: 8364920
[TBL] [Abstract][Full Text] [Related]
39. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
Tsuruo T
Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
[TBL] [Abstract][Full Text] [Related]
40. Increase of vinblastine accumulation by inhibitors of calmodulin-dependent cell functions in rat ascites hepatoma AH66 cells.
Wakusawa S; Takeda K; Miyamoto K; Hidaka H
Anticancer Res; 1992; 12(6B):2021-4. PubMed ID: 1363514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
